ZIVO - Zivo Bioscience Recent Insider Activity | Benzinga
MARK STROME, 10% Owner at Zivo Bioscience (NASDAQ:ZIVO), reported a large insider buy on October 30, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that STROME purchased 40,000 shares of Zivo Bioscience. The total transaction amounted to $199,600.
Zivo Bioscience shares are trading down 0.0% at $2.6 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however, ...